Kruse Klausen M, Thomsen M, Wortwein G, Fink-Jensen A
WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicines owenhaskins Jun 25, 2024 4 min read The World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for treatment of type 2 diabetes and obesity in some countries
However, recent studies revealed its potential for weight loss in non-diabetic individuals as well
Gmez V, Eykyn TR, Mustapha R, Flores-Borja F, Male V, Barber PR, Patsialou A, Green R, Panagaki F, Li CW, et al
Research published in the Journal of Clinical Endocrinology and Metabolism has shown that exercise increases GLP-1 receptor expression and enhances the hormone's effects on appetite regulation and glucose metabolism